
Experimental treatment shows promise against deadly Andes hantavirus strain
An experimental treatment using tocilizumab is showing effectiveness against the Andes hantavirus strain in Argentina's Patagonia region. Local doctor Fernando Tortosa developed the treatment, which aims to curb the exaggerated inflammatory response that makes the virus lethal. Nazareno Eggers, a survivor, credits the treatment and a healthy lifestyle for his recovery.


